Roger Frechette

Roger Frechette Email and Phone Number

Entrepreneur in Residence, US-Israel HealthTech Hub Accelerator @ Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA
Boston, MA, US
Roger Frechette's Location
Greater Boston, United States, United States
Roger Frechette's Contact Details
About Roger Frechette

Roger Frechette is a Entrepreneur in Residence, US-Israel HealthTech Hub Accelerator at Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA. He possess expertise in drug discovery, biotechnology, drug development, pharmaceutical industry, lifesciences and 43 more skills. Colleagues describe him as "Roger has worked with GRObio as a Business Development Lead for several years. He has a rare combination of experience from drug development to alliance management across companies large and small that make him an excellent asset particularly for companies seeking early-stage growth. He has made invaluable contributions to our business development, corporate strategy and market assessment efforts. He has a vast network across verticals within the pharmaceutical industry, particularly around the Boston biotech ecosystem, that make him an ideal partner for building key relationships. Roger also provides a flexible working model that adjusts to a company's evolving needs. I highly recommend working with Roger if given the opportunity.", "I had the privilege of working with Roger when he was our MVA ambassador in Boston. I very much enjoyed working with Roger. He is not only very pleasant to collaborate with but also highly competent, dedicated and knowledgeable and has an extensive network. I would thus strongly recommend Roger to anyone within Life Science with an interest in exploring business possibilities on the US east coast in general and the Boston/Massachusetts area in particular.", and "In addition to starting up the chemistry group, Roger was a highly effective Project Manager of our multi-disciplinary teams for two pharmaceutical corporation drug discovery collaborations at RiboGene. Roger ensured that all aspects of the collaborations were well coordinated and a positive, professional relationship with our partners was maintained."

Roger Frechette's Current Company Details
Advanced Regenerative Manufacturing Institute (ARMI) | BioFabUSA

Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa

View
Entrepreneur in Residence, US-Israel HealthTech Hub Accelerator
Boston, MA, US
Website:
armiusa.org
Employees:
106
Roger Frechette Work Experience Details
  • Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa
    Entrepreneur In Residence, Us-Israel Healthtech Hub Accelerator
    Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa
    Boston, Ma, Us
  • Stealth - Therapeutics Biotech
    Advisory Board Member
    Stealth - Therapeutics Biotech Nov 2024 - Present
  • New England Pharmassociates, Llc
    Co-Founder And Principal: Mentor - Advisor - Fractional Executive
    New England Pharmassociates, Llc May 2009 - Present
    Greater Boston, Massachusetts, Us
    NEPAssociates (NEPA) provides advisory and fractional executive services to life science enterprises, specializing in strategic planning/business development, commercial market assessment, and R&D Operations.
  • Enet - Boston Entrepreneurs'​ Network
    Executive Committee Member
    Enet - Boston Entrepreneurs'​ Network Oct 2018 - Present
    Us
  • Enet - Boston Entrepreneurs'​ Network
    Member Administrative Board
    Enet - Boston Entrepreneurs'​ Network Sep 2014 - Present
    Us
    Organizing events focused on educational topics to help entrepreneurs to succeed. Engaging with entrepreneurs, executives, investors and executives in life sciences to network and learn with ENET's traditional Tech audience in the interest of expanding the rate of Biotech/High tech convergence.A Boston Area institution since 1991, ENET holds 20 meetings each year on topics of interest to entrepreneurs in software, electronics, internet, medical device, biotech and other technology based fields. ENET offers valuable educational content and the unique opportunity for multidisciplinary networking with new and experienced entrepreneurs and the myriad of professionals who support them with mentoring, investment and essential services.ENET also hosts an annual entrepreneurs' sunset networking Boston Harbor cruise, the EntrepreneurSHIP - good food, great networking - perfect for wallflowers...no place to hide.
  • Enet - Boston Entrepreneurs'​ Network
    Vice-Chair - Life Sciences
    Enet - Boston Entrepreneurs'​ Network May 2019 - Aug 2024
    Us
  • Akelos Inc
    Business Advisor
    Akelos Inc Jul 2023 - Present
    New York, New York, Us
  • Akelos Inc
    Director Business Develoment And Operations
    Akelos Inc Jun 2019 - Jun 2023
    New York, New York, Us
    NEPA Engagement, serving as virtual executive in business development and operations. Akelos in an innovative research-based BioPharmaceutical company founded to address the Opioid epidemic through safe alternatives for the treatment of pain - the Company is actively seeking investment to support its initial goals of developing non-opioid, non-addictive therapeutics for peripheral neuropathic pain. Please follow the link below for details: https://invest.akelosinc.com
  • Concerto Biosciences
    Chief Business Officer
    Concerto Biosciences Jul 2023 - Jun 2024
    Cambridge, Ma, Us
  • Concerto Biosciences
    Business Development/Cbo
    Concerto Biosciences Sep 2021 - Jul 2023
    Cambridge, Ma, Us
    Concerto Biosciences rebuilds microbial communities in, on, and around us to heal our bodies and our planet. The company's platform, kChip, is the first-ever discovery engine to experimentally measure millions of microbial interactions and identify inter-species interaction networks that are responsible for community behavior and microbiome function. We use kChip-derived knowledge to design a new class of products we call “ensembles”—combinations of microbes that work in concert to shepherd damaged microbial communities to health. In addition to beneficial microbial ensembles, kChip also allows us to discover byproducts of microbes (i.e., postbiotics) or small molecules (i.e., prebiotics) that alter microbial function and ultimately benefit the health of the target host (human, animal, plant).NEPA Engagement: Fractional business development executive
  • Gro Biosciences
    Business Development
    Gro Biosciences Sep 2018 - May 2022
    Boston, Ma, Us
    NEPA Engagement, various roles: asset valuation/stratification, advisory support for financing, virtual business development executive.
  • Pistoia Alliance, Inc.
    Consultant, Business Development
    Pistoia Alliance, Inc. Aug 2018 - Jul 2020
    Wakefield, Massachusetts, Us
    NEPA engagement, serving as US-based business development consultant for the Pistoia Alliance. Contributed to development of symposia, conferences and webinars. Conducted industry outreach to prospective new members, establishing a growing US-based business pipeline, with multiple new members enrolled. Created a new Emerging Science & Technology Interest Group - established and managed a Steering Committee of KOLs, launched multiple introductory events on important new topics, including the microbiome in human health and quantum computing.In a complex and dynamic environment of science, technology and medicine, the Pistoia Alliance lowers barriers to R&D innovation, enabling the development and incubation of integrated healthcare solutions through pre-competitive collaboration.
  • Procela Partners
    Partner
    Procela Partners Jul 2017 - Aug 2019
    Partnered with Procela, a small group of highly successful life sciences executives and independent consultants.Procela’s experienced team of executives have a proven track record in successfully founding, scaling and commercializing life sciences companies in the US, Europe and Internationally. With offices in Boston, Brussels, California, Dublin, and London, Procela offers a full suite of services that enable life sciences companies to establish and grow their business in Europe and the US.
  • Cn Bio Innovations
    Director Partnering & Licensing
    Cn Bio Innovations Aug 2016 - Dec 2017
    Cambridge, England, Gb
    NEPA engagement - led the effort to expand CN Bio's business interests in the US, focusing especially on the Greater Boston Life Science Super-Cluster. Advised the CEO on strategy for in-licensing opportunities and represented the company's technology to the area's leading Pharma/Biotech companies. Identified early interest and champions within the industry to build a pipeline of prospective business partners and worked with the CN Bio team to close multiple early-stage collaboration deals.CN Bio Innovations, headquartered in the United Kingdom, is a pioneer in Organ-on-Chip platforms for the development of better, safer medicines for serious human diseases.
  • Apeiron Synthesis
    Senior Director Business Development
    Apeiron Synthesis Sep 2015 - Jul 2017
    Wrocław, Dolnośląskie, Pl
    NEPA engagement, serving as Apeiron's virtual 'boots on the ground' business development executive in the US for establishing visibility and identifying prospective business partners in the Pharmaceutical and Flavors and Fragrances industry sectors. Built awareness of the company's capabilities with high visibility presentations and by organizing topical symposia. Established a pipeline of business prospects, technology evaluation projects and assisted with closing multiple deals.Apeiron Synthesis, based in Poland, is a chemical process innovation leader, leveraging unrivaled knowledge and experience with olefin metathesis catalyst design and process optimization to dramatically increase efficiency and lower costs for synthetic chemistry processes from bench-top to plant.
  • Medicon Valley Alliance
    Mva Ambassador
    Medicon Valley Alliance Jun 2014 - Jun 2015
    Copenhagen S, Dk
    NEPA engagement, serving as Boston Area Ambassador - representing MVA and various Danish/Swedish industry, academic and government stakeholders seeking to work with MA-based life science companies and academic institutions. Assisted multiple individual companies with new business connections; organized and hosted delegations of MVA regional leadership to meet with scientific and business innovation leaders in the US Northeast.MVA is a non-profit membership organization representing life sciences organizations in the Danish-Swedish life science cluster - Medicon Valley.
  • North Shore Innoventures
    Advisor And Eir
    North Shore Innoventures Jun 2011 - Mar 2014
    New England PharmAssociates (NEPA) provided a fully equipped biotech lab/office suite to enable NSIV's biotech incubator operation. NEPA Principals were Sustaining Sponsors and Entrepreneurs-in-Residence, providing on-demand advisory services to the NSIV and portfolio companies.North Shore InnoVentures (NSIV) operates a business incubator to nurture innovative early-stage companies and support sustained economic growth in our region. Established in 2008, cleantech operations launched in 2008 and biotech operations launched in 2010, NSIV is committed to technology innovation and helping entrepreneurs flourish.
  • Biota Holdings Limited (Biota Pharmaceuticals, Inc., Acquired By Avirogen)
    Consultant
    Biota Holdings Limited (Biota Pharmaceuticals, Inc., Acquired By Avirogen) Mar 2010 - Jun 2011
    Founded New England PharmAssociates, LLC to provide advisory and operational services for Biota's newly acquired portfolio programs derived from MaxThera (Beverly, MA) and Prolysis (Oxford, UK). Operated a laboratory facility in Beverly, MA intended to gradually transition acquired assets into the Biota R&D portfolio.
  • Maxthera, Inc.
    Co-Founder; Vp Chemistry And R&D Operations
    Maxthera, Inc. Aug 2004 - Apr 2010
    Founded MaxThera with an exclusive license to the drug discovery portfolio from Genome Therapeutics Corporation. The goal: to develop new treatments for bacterial infections - especially for infections caused by bacteria that have become resistant to current drugs. Wrote grants (NIH NIAID and Project BioShield) to raise US $3 million in non-dilutive funds. Designed and implemented a highly capital efficient, semi-virtual operating model that enabled substantial R&D progress with minimal capital investment.Responsibility for chemistry strategy and R&D operations - oversight of hiring, identification and management of outsourced R&D vendors, and led business development activities.Successfully exited company in early 2010 with sale of assets to Biota Holdings Limited, of Melbourne Australia.
  • Nepassociates
    Founder And Principal
    Nepassociates Feb 2003 - Apr 2009
    A sole-proprietorship consultancy in life sciences offering R&D strategy, drug discovery and project management advisory services.
  • Paratek Pharmaceuticals, Inc.
    Project Director
    Paratek Pharmaceuticals, Inc. Jan 2000 - Jan 2003
    Boston, Ma, Us
    Project Director at this Boston-based pharmaceutical company focused on synthetically modified tetracyclines and antibiotic resistance. Leader of the multi-disciplinary internal R&D effort and alliance manager for the strategic partnership with GlaxoWellcome (Madrid, Spain) resulting in the identification of Omadacycline (formerly PTK-0796) and Sarecycline, two novel tetracycline antibiotics. Planned and executed the semi-virtual IND-enabling early development program for omadacycline, coordinating efforts of internal experts, consultants and international partners to complete GLP toxicology, CMP scale-up, formulation development and phase 1 plan. Omadacycline and Sarecycline were approved by the FDA in 2018. The Paratek Pharmaceuticals drug discovery team, responsible for the inventions of Omadacycline and Sarecycline, were recognized with the American Chemical Society's "Heroes of Chemistry" award in 2019, at the ACS National Meeting in San Diego.
  • Ribogene, Inc.
    Associate Director Of Chemistry
    Ribogene, Inc. 1998 - 2000
    Head of chemistry; initiated chemistry operations at RiboGene. Project Leader for two antibacterial programs, responsible for internal R&D. Alliance manager for the strategic partnership with Dainippon Pharmaceuticals, of Osaka Japan.
  • R. W. Johnson Pharmaceutical Reserarch Institute
    Senior Scientist
    R. W. Johnson Pharmaceutical Reserarch Institute Oct 1989 - Feb 1998
    Medicinal chemist on numerous project teams in inflammation, cardiovascular, reproductive health, anti-fungal and anti-bacterial therapeutic areas. Innovator in integrating principles and methods of combinatorial chemistry with traditional medicinal chemistry and computational methods. Corporate citizenship - served as Chair of Site Safety Committee.

Roger Frechette Skills

Drug Discovery Biotechnology Drug Development Pharmaceutical Industry Lifesciences Technology Transfer Life Sciences Start Ups R&d Biopharmaceuticals Strategy Chemistry Commercialization Cro Clinical Trials Medicinal Chemistry Organic Chemistry Clinical Development Entrepreneurship Business Development Pharmaceutics Biochemistry Glp Licensing Genomics Pharmacology Product Development Venture Capital Oncology Research And Development Cross Functional Team Leadership Mergers And Acquisitions Immunology Laboratory Patents Formulation Strategic Alliances Validation Fda Science Gmp Project Management Lead Change Lead Generation Lead Optimisation Strategic Partnerships Assay Development Good Laboratory Practice

Roger Frechette Education Details

  • Yale University
    Yale University
    Organic Chemistry
  • Wesleyan University
    Wesleyan University
    Organic Chemistry
  • College Of The Holy Cross
    College Of The Holy Cross
    Chemistry
  • Berlin Senior High School
    Berlin Senior High School

Frequently Asked Questions about Roger Frechette

What company does Roger Frechette work for?

Roger Frechette works for Advanced Regenerative Manufacturing Institute (Armi) | Biofabusa

What is Roger Frechette's role at the current company?

Roger Frechette's current role is Entrepreneur in Residence, US-Israel HealthTech Hub Accelerator.

What is Roger Frechette's email address?

Roger Frechette's email address is rf****@****tes.com

What is Roger Frechette's direct phone number?

Roger Frechette's direct phone number is +161748*****

What schools did Roger Frechette attend?

Roger Frechette attended Yale University, Wesleyan University, College Of The Holy Cross, Berlin Senior High School.

What skills is Roger Frechette known for?

Roger Frechette has skills like Drug Discovery, Biotechnology, Drug Development, Pharmaceutical Industry, Lifesciences, Technology Transfer, Life Sciences, Start Ups, R&d, Biopharmaceuticals, Strategy, Chemistry.

Who are Roger Frechette's colleagues?

Roger Frechette's colleagues are Kyra Woodworth, Sarah Piet, Joshua Ozoria, Scott D. Packard Phd, Kieran Mccurdy, Joseph P. Zitelli, Lorna Smith.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.